Advocates are still fighting to get the psychedelic drug approved as a mental health treatment, despite its rejection by the FDA's advisory committee in June. They face an uphill battle.
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.
Busts of psilocybin mushrooms went way up from 2017 to 2022, a new study finds, even as the psychedelic drug's potential benefits have been explored by scientists.
Ketamine, approved as an anesthetic in 1970, is emerging as a major alternative mental health treatment. But more than 500 clinics have popped up with little regulation, and treatment varies widely.
Chaplains provide spiritual counsel at some of life's most raw moments. With psychedelic legalization spreading, some chaplains think this role should include facilitating psychedelic trips.
Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.
